Advertisement

Experientia

, Volume 23, Issue 11, pp 905–906 | Cite as

The antilipolytic effects of 3,5-dimethylisoxazole and possible carboxylic acid metabolites

  • J. N. Pereira
  • G. F. Holland
Specialia Chimica. Biochimica. Biophysica

Keywords

Free Fatty Acid Isoxazole Plasma Free Fatty Acid Plasma Free Fatty Acid Level Free Fatty Acid Release 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Zusammenfassung

Von allen möglichen Isoxazolcarbonsäurenstoffwechselprodukten von 3,5-Dimethylisoxazol (3,5-DMI), die untersucht wurden, war nur die 3-Methylisoxazol-5-carbonsäure wirksam genug, um die auffallende Wirkung von 3,5-DMI auf unveresterte Fettsäurespiegel in normalen Hunden zu erklären.

References

  1. 1.
    W. E. Dulin andG. C. Gerritsen, Fedn Proc. Fedn Am. Socs exp. Biol.23, 502 (1964).Google Scholar
  2. 2.
    D. L. Smith, A. A. Forist andW. E. Dulin, J. med. Chem.8, 350 (1965).CrossRefPubMedGoogle Scholar
  3. 3.
    D. L. Smith, A. A. Forist andG. C. Gerritsen, J. Pharmacol. exp. Ther.150, 316 (1965).PubMedGoogle Scholar
  4. 4.
    W. E. Dulin andG. C. Gerritsen, Proc. Soc. exp. Biol. Med.121, 777 (1966).CrossRefPubMedGoogle Scholar
  5. 5.
    V. P. Dole, J. clin. Invest.35, 150 (1956).CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    W. E. Dulin, G. H. Lund andG. C. Gerritsen, Proc. Soc. exp. Biol. Med.118, 499 (1965).CrossRefPubMedGoogle Scholar

Copyright information

© Birkhäuser Verlag 1967

Authors and Affiliations

  • J. N. Pereira
    • 1
  • G. F. Holland
    • 1
  1. 1.Medical Research LaboratoriesChas. Pfizer & Co., Inc.GrotonUSA

Personalised recommendations